Tyra Biosciences, Inc. (TYRA) Latest Stock News & Headlines
Get the latest Tyra Biosciences, Inc. (TYRA) stock news and headlines to help you in your trading and investing decisions.
Tyra Biosciences Announces Poster Presentations at 2025 ASCO ...
4 days ago · About TYRA-430. TYRA-430 is an oral, investigational FGFR4/3-biased inhibitor for FGF19 + /FGFR4-driven cancers. The US Food and Drug Administration has cleared Tyra's Investigational New Drug application to proceed with a Phase 1 clinical study of TYRA-430. The Phase 1 study will be a multicenter, open-label, first-in-human study of TYRA-430 ...
Tyra Biosciences, Inc. (TYRA) Stock Price, News, Quote & History ...
Find the latest Tyra Biosciences, Inc. (TYRA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Tyra Biosciences Inc. - MarketWatch
Jan 14, 2025 · TYRA | Complete Tyra Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Tyra Looks to Challenge J&J’s Balversa With Early Data for FGFR3 ...
Oct 25, 2024 · Tyra Biosciences on Thursday unveiled early proof-of-concept data for its investigational and potential first-in-class FGFR3 inhibitor TYRA-300, touting “encouraging” anti-tumor action in heavily pretreated patients with metastatic urothelial carcinoma.
Tyra Biosciences Receives IND Clearance from FDA to Proceed …
Oct 28, 2024 · TYRA-300 is a potential first-in-class, investigational, oral, FGFR3-selective inhibitor designed to avoid the toxicities associated with inhibition of FGFR1, FGFR2 and FGFR4.
News Releases - Tyra Bio Investor Relations
Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Pediatric Achondroplasia (BEACH301)
Tyra Biosciences, Inc. (TYRA) Latest Stock News | Seeking Alpha
Get the latest news and real-time alerts from Tyra Biosciences, Inc. (TYRA) stock at Seeking Alpha.
Tyra Biosciences granted IND clearance from FDA for Phase 2 …
Oct 28, 2024 · Tyra Biosciences (TYRA) announced that the FDA cleared its Investigational New Drug application for Tyra-300 allowing the company to proceed with a Phase 2 clinical trial of Tyra-300 for children...
Tyra Biosciences, Inc. (TYRA) Stock Price, Quote, News & Analysis ...
A high-level overview of Tyra Biosciences, Inc. (TYRA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
- Some results have been removed